These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
612 related articles for article (PubMed ID: 29726120)
1. Nanoscale platforms for messenger RNA delivery. Li B; Zhang X; Dong Y Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Mar; 11(2):e1530. PubMed ID: 29726120 [TBL] [Abstract][Full Text] [Related]
2. Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing. Qiu M; Li Y; Bloomer H; Xu Q Acc Chem Res; 2021 Nov; 54(21):4001-4011. PubMed ID: 34668716 [TBL] [Abstract][Full Text] [Related]
3. An overview of lipid constituents in lipid nanoparticle mRNA delivery systems. Wu S; Lin L; Shi L; Liu S Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(4):e1978. PubMed ID: 38965928 [TBL] [Abstract][Full Text] [Related]
4. Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications. Wang C; Zhang Y; Dong Y Acc Chem Res; 2021 Dec; 54(23):4283-4293. PubMed ID: 34793124 [TBL] [Abstract][Full Text] [Related]
5. Rational design of lipid nanoparticles: overcoming physiological barriers for selective intracellular mRNA delivery. Zhao Y; Wang ZM; Song D; Chen M; Xu Q Curr Opin Chem Biol; 2024 Aug; 81():102499. PubMed ID: 38996568 [TBL] [Abstract][Full Text] [Related]
6. Nanoparticle technology for mRNA: Delivery strategy, clinical application and developmental landscape. Li X; Qi J; Wang J; Hu W; Zhou W; Wang Y; Li T Theranostics; 2024; 14(2):738-760. PubMed ID: 38169577 [TBL] [Abstract][Full Text] [Related]
7. Nanoparticles for nucleic acid delivery: Applications in cancer immunotherapy. Mukalel AJ; Riley RS; Zhang R; Mitchell MJ Cancer Lett; 2019 Aug; 458():102-112. PubMed ID: 31100411 [TBL] [Abstract][Full Text] [Related]
8. Cell-Selective Messenger RNA Delivery and CRISPR/Cas9 Genome Editing by Modulating the Interface of Phenylboronic Acid-Derived Lipid Nanoparticles and Cellular Surface Sialic Acid. Tang Q; Liu J; Jiang Y; Zhang M; Mao L; Wang M ACS Appl Mater Interfaces; 2019 Dec; 11(50):46585-46590. PubMed ID: 31763806 [TBL] [Abstract][Full Text] [Related]
9. Materials for non-viral intracellular delivery of messenger RNA therapeutics. Kauffman KJ; Webber MJ; Anderson DG J Control Release; 2016 Oct; 240():227-234. PubMed ID: 26718856 [TBL] [Abstract][Full Text] [Related]
10. Delivery of synthetic mRNAs for tissue regeneration. Steinle H; Weber J; Stoppelkamp S; Große-Berkenbusch K; Golombek S; Weber M; Canak-Ipek T; Trenz SM; Schlensak C; Avci-Adali M Adv Drug Deliv Rev; 2021 Dec; 179():114007. PubMed ID: 34710530 [TBL] [Abstract][Full Text] [Related]
11. Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing. Zhang X; Zhao W; Nguyen GN; Zhang C; Zeng C; Yan J; Du S; Hou X; Li W; Jiang J; Deng B; McComb DW; Dorkin R; Shah A; Barrera L; Gregoire F; Singh M; Chen D; Sabatino DE; Dong Y Sci Adv; 2020 Aug; 6(34):. PubMed ID: 32937374 [TBL] [Abstract][Full Text] [Related]
12. A Systematic Study of Unsaturation in Lipid Nanoparticles Leads to Improved mRNA Transfection In Vivo. Lee SM; Cheng Q; Yu X; Liu S; Johnson LT; Siegwart DJ Angew Chem Int Ed Engl; 2021 Mar; 60(11):5848-5853. PubMed ID: 33305471 [TBL] [Abstract][Full Text] [Related]
13. Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems. Guan S; Rosenecker J Gene Ther; 2017 Mar; 24(3):133-143. PubMed ID: 28094775 [TBL] [Abstract][Full Text] [Related]